Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma,Immunity, Inflammation and Disease

当前位置： X-MOL 学术 › Immun. Inflamm. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma
Immunity, Inflammation and Disease ( IF 3.1 ) Pub Date : 2021-08-25 , DOI: 10.1002/iid3.513
Yuqin Qiu ₁ , Xiaogang Wang ₂ , Zhenjia Fan ₁ , Shanhui Zhan ₁ , Xin Jiang ₁ , Jinchang Huang _{1,

3}

Affiliation

Patients with advanced clear cell renal cell carcinoma (ccRCC) have a poor prognosis and lack effective prognostic biomarkers. N6-methyladenosine-related lncRNAs (m6A-related long noncoding RNAs [lncRNAs]) have been confirmed to be associated with the development of multiple tumors, but its role in ccRCC is not clear.

中文翻译：

透明细胞肾细胞癌中 N6-甲基腺苷相关长链非编码 RNA 预后特征、免疫检查点和免疫细胞浸润的综合分析

晚期透明细胞肾细胞癌 (ccRCC) 患者预后较差，缺乏有效的预后生物标志物。N6-甲基腺苷相关的lncRNA（m6A相关的长链非编码RNA [lncRNA]）已被证实与多种肿瘤的发生有关，但其在ccRCC中的作用尚不清楚。

更新日期：2021-08-25

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文